Literature DB >> 3524423

Hydrophobic polyoxins are resistant to intracellular degradation in Candida albicans.

H A Smith, P Shenbagamurthi, F Naider, B Kundu, J M Becker.   

Abstract

Two novel polyoxins, N-epsilon-(octanoyl)-lysyl-uracil polyoxin C (Oct-Lys-UPOC) and N-gamma-(octyl)-glutaminyluracil polyoxin C (Oct-Gln-UPOC), were synthesized by reacting uracil polyoxin C with the appropriate amino acid p-nitrophenyl ester. Oct-Lys-UPOC and Oct-Gln-UPOC were strong inhibitors (Kis = 1.7 X 10(-6)M) of chitin synthetase from Candida albicans membrane preparations. In a permeabilized-cell assay, Oct-Gln-UPOC had a 10-fold-lower inhibitory activity toward chitin synthetase than did the Oct-Lys-UPOC analog. Both compounds were resistant to hydrolysis by a cell extract of C. albicans H317; however, Oct-Gln-UPOC was hydrolyzed with a half-life of 23 min by a permeabilized-cell preparation. Oct-Lys-UPOC was resistant to hydrolysis by permeabilized cells. Oct-Gln-UPOC and Oct-Lys-UPOC did not compete with the transport of peptides or uridine into the cell. At concentrations up to 2 mM these two new polyoxins were ineffective in the inhibition of cell growth or reduction of cell viability, but they induced aberrant morphologies in C. albicans at a concentration of 0.25 mM. These data suggest that polyoxins containing hydrophobic amino acids retain strong chitin synthetase inhibitory activity and are resistant to cellular hydrolysis. They provide the first example of effective synthetic chitin synthetase inhibitors which are stable inside C. albicans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524423      PMCID: PMC180359          DOI: 10.1128/AAC.29.1.33

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Polyoxin analogs. III. Synthesis and biological activity of aminoacyl derivatives of polyoxins C and L.

Authors:  T Azuma; T Saita; K Isono
Journal:  Chem Pharm Bull (Tokyo)       Date:  1977-07       Impact factor: 1.645

2.  Commitment to germ tube or bud formation during release from stationary phase in Candida albicans.

Authors:  L H Mitchell; D R Soll
Journal:  Exp Cell Res       Date:  1979-04       Impact factor: 3.905

3.  Activation of chitin synthetase in permeabilized cells of a Saccharomyces cerevisiae mutant lacking proteinase B.

Authors:  M P Fernandez; J U Correa; E Cabib
Journal:  J Bacteriol       Date:  1982-12       Impact factor: 3.490

Review 4.  Antifungal agents useful in therapy of systemic fungal infections.

Authors:  G Medoff; J Brajtburg; G S Kobayashi; J Bolard
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

Review 5.  Synthesis of the yeast cell wall and its regulation.

Authors:  E Cabib; R Roberts; B Bowers
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

6.  Anti-Candida activity of polyoxin: example of peptide transport in yeasts.

Authors:  R J Mehta; W D Kingsbury; J Valenta; P Actor
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

7.  An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.

Authors:  K L Lee; H R Buckley; C C Campbell
Journal:  Sabouraudia       Date:  1975-07

8.  Synthesis and biological activity of tripeptidyl polyoxins as antifungal agents.

Authors:  F Naider; P Shenbagamurthi; A S Steinfeld; H A Smith; C Boney; J M Becker
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

9.  Peptide transport in Candida albicans.

Authors:  D A Logan; J M Becker; F Naider
Journal:  J Gen Microbiol       Date:  1979-09

10.  Design of anticandidal agents: synthesis and biological properties of analogues of polyoxin L.

Authors:  P Shenbagamurthi; H A Smith; J M Becker; A Steinfeld; F Naider
Journal:  J Med Chem       Date:  1983-10       Impact factor: 7.446

View more
  1 in total

Review 1.  Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Authors:  C A Lyman; T J Walsh
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.